Huntington’s disease provides new cancer weapon
Scientists have discovered why Huntington's is so toxic to cancer cells and harnessed it for a novel approach to treat cancer...
List view / Grid view
Scientists have discovered why Huntington's is so toxic to cancer cells and harnessed it for a novel approach to treat cancer...
Scientists have discovered a molecule that enhances cartilage regeneration and decreases inflammation.
Scientists have described an experimental molecular therapy that restores insulation on peripheral nerves in mice, improves limb function, and results in less observable discomfort...
Chemicals that attract specialised immune cells toward tumours could be used to develop better immunotherapies for cancer patients...
Scientists offer important information for understanding de novo DNA methlylation...
Researchers have bioengineered organs that are free from the risk of tumour growth--and of sufficient volume and size for viable transplant...
New assay may allow screening for 'actionable' gene mutations in routinely acquired archival biopsies...
Using nuclear medicine, German researchers have found a way to accurately differentiate cancerous tissue from healthy tissue in prostate cancer patients.
A new study has established that hybrid-capture sequencing is the method of choice for sequencing “actionable” gene mutations across the most common forms of lymphoid cancer.
Researchers have made an important step forward in the design of drugs that fight the hepatitis B virus, which can cause liver failure and liver cancer...
Human eggs have been fully grown in a laboratory, in a move that could lead to improved fertility treatments...
Scientists have discovered that the amino acid asparagine is essential for breast cancer spread, and by restricting it, cancer cells stopped invading other parts of the body in mice.
Scientists have developed a CRISPR gene-editing technique that can potentially correct a majority of mutations that cause DMD...
Scientists in Denmark have made it possible to rank the risk of resistance genes and predict the evolution of existing and future drugs.
Dartmouth scientists have successfully uncovered a therapeutic approach that targets aggressive brain cancer stem cells and could lead to improved patient survival.